Response to radiotherapy |
Complete response |
12(48%) |
Partial response |
10(40%) |
Stable disease |
03(12%) |
Disease status on last follow up |
No evidence of disease |
12(48%) |
Local recurrence |
08(32%) |
Metastatic disease |
04(16%) |
Lost to follow up |
04(16%) |
Survival |
Median follow up |
32-months (range 7-76months) |
Median Survival |
51 months |
24months survival |
72% |
|